SCHEMBL3547734

SCHEMBL3547734

COCCOc1c(N)ccc(C(=O)O)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
NPC1 O15118 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
SENP8 Q96LD8 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
ALDH1A1 P00352 3/20 0.37
PRKAB2 O43741 1/20 0.37
PRKAG1 P54619 1/20 0.37
PRKAA2 P54646 1/20 0.37
PRKAA1 Q13131 1/20 0.37
PRKAG3 Q9UGI9 1/20 0.37
PRKAG2 Q9UGJ0 1/20 0.37
PRKAB1 Q9Y478 1/20 0.37
PTGER4 P35408 1/20 0.37
KMT2A Q03164 4/20 0.37
TDP1 Q9NUW8 3/20 0.37
MEN1 O00255 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9733862 0.82 HSD17B10 (0.37) KDM4ERAB9AHSD17B10ALDH1A1PRKAB2
SCHEMBL2081501 0.80 TDP1 (0.47) KDM4ENPC1CASP3RAB9ASENP8
SCHEMBL24886348 0.79 HPGD (0.41) KDM4ENPC1RAB9AHSD17B10ALDH1A1
SCHEMBL646150 0.78 PTGER4 (0.35) ALDH1A1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL4077849 0.74 PRKAB2 (0.45) KDM4EHSD17B10ALDH1A1PRKAB2PRKAG1
SCHEMBL23882042 0.74 ALDH1A1 (0.47) KDM4ENPC1RAB9AHSD17B10ALDH1A1
SCHEMBL3544037 0.73 ALDH1A1 (0.49) KDM4ENPC1CASP3RAB9ASENP8
SCHEMBL28382463 0.73 HTT (0.41) KDM4EALDH1A1KMT2ATDP1MEN1
SCHEMBL22068718 0.72 KDM4E (0.42) KDM4ENPC1CASP3RAB9ASENP8
SCHEMBL2216094 0.72 ALDH1A1 (0.57) KDM4EHSD17B10ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709471-B2 Compounds ASTRAZENECA AB (SE) 2010-05-04 US disclosed
US-20080009482-A1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2008-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009482-A1 NOVEL COMPOUNDS CYP11B2, CYP11B1, CYP46A1 KDM4E 3977/4885NPC1 13/4885CASP3 1058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.